Question

How are compounded sterile preparations (CSP) risk levels determined?

A) By the medication cost
B) By the number of ingredients
C) By the complexity of the compounding process
D) By the expiration date of the ingredients

Answer 1

The risk levels of compounded sterile preparations (CSP) are typically determined by the complexity of the compounding process. Factors such as type and number of ingredients used, manipulations involved, and potential for errors are considered.

Step-by-step explanation:

The risk levels of compounded sterile preparations (CSP) are typically determined by the complexity of the compounding process. The level of risk is assessed based on factors such as the type and number of ingredients used, the manipulations involved in the compounding process, and the potential for microbial contamination or other errors.

For example, a CSP that requires aseptic techniques such as sterile filtration or a laminar airflow hood would be considered higher risk compared to a simple compounding process that involves mixing two liquid medications.

The expiration date of the ingredients, medication cost, or number of ingredients may not directly determine the risk level of CSPs.